SURABAYA, Indonesia, May 2, 2025 /PRNewswire/ -- Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Siemens Healthineers received premarket approval for the ...

The Food and Drug Administration (FDA) has approved the MAMMOMAT Inspiration with Tomosynthesis Option – the breast tomosynthesis add-on option for Siemens Healthcare’s MAMMOMAT Inspiration digital ...

The UK’s largest not-for-profit healthcare provider Nuffield Health has as part of its wider investment programme improved its breast screening service with a technology refresh which includes six ...

The system adapts flying focal spot technology used in CT scanners to counter the blurring that can happen as the X-ray sensor rotates to build a 3D image. (Siemens Healthineers) Siemens Healthineers ...

The FDA has given premarket approval to the 3D breast-imaging technology of Siemens Healthineers’ Mammomat B.brilliant mammography platform. The Mammomat B.brilliant platform was already FDA approved ...

ScreenPoint Medical has raised $16m to advance the global expansion of its artificial intelligence (AI) screening tool for breast cancer detection, with ongoing participation from Siemens Healthineers ...